ORTHOREBIRTH Co., Ltd.


President & CEO

Yasutoshi Nishikawa

Description

A medical device startup that has commercialised microfibre scaffold manufacturing technology. Its flagship product is ReBOSSIS®, an absorbable, cotton-like synthetic bone void filler.

Impact

By commercialising ReBOSSIS, a bio-resorbable, microfiber-based bone void filler, ORTHOREBIRTH is transforming bone repair: enabling faster, safer healing for fractures and spinal disorders, reducing the burden on older populations, and broadening access to regenerative treatments. Their technology supports both surgical bone repair and next-generation regenerative medicine – offering a step-change in musculoskeletal health and contributing to a more sustainable, impact-driven healthcare paradigm.

Investment Themes
  1. Empowering Holistic Well-Being by inspiring positive lifestyle and activity choices.We invest in products and services that motivate individuals towards health-positive decisions, emphasizing the critical role of consumer behavior in wellness.